Hyperactivity Disorder Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Hyperactivity Disorder stocks.

Hyperactivity Disorder Stocks Recent News

Date Stock Title
May 31 LLY Top Research Reports for Eli Lilly, T-Mobile & BHP
May 31 ALKS Why Is Alkermes (ALKS) Down 2.7% Since Last Earnings Report?
May 31 LLY Is Eli Lilly And Co (NYSE:LLY) the Best Weight Loss Stock to Buy in 2024?
May 31 LLY Goldman Sees Obesity-Drug Market Growing to $130 Billion by 2030
May 31 LLY ZTS, SYK, LLY: Which Healthcare Stock Is the Best Buy?
May 30 LLY Ro CEO on GLP-1 drug shortage: US healthcare is '1 of 1'
May 30 SUPN Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
May 30 LLY New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk
May 30 LLY 3 Stocks With High Yield Growth For Long-Term Passive Income
May 30 LLY Why Is Lilly (LLY) Up 4.5% Since Last Earnings Report?
May 30 LLY Goldman Sachs raises obesity drug market estimate to $130B
May 30 LLY Costco, Eli Lilly Near New Highs; That Doesn't Scare Mutual Funds
May 30 LLY Urban Outfitters, Eli Lilly And 2 Other Stocks Insiders Are Selling
May 30 COLL Insider Sale: EVP & CFO Colleen Tupper Sells Shares of Collegium Pharmaceutical Inc (COLL)
May 29 LLY Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmaker
May 29 LLY FDA Conditionally Approves Eli Lilly's Thyroid Cancer Drug For Pediatric Patients With Certain Mutations
May 29 ALKS Alkermes to Participate in Two Upcoming Investor Conferences
May 29 LLY Eli Lilly's Retevmo Gets FDA Accelerated Approval for Kids With RET-altered Thyroid Cancer, Solid Tumors
May 29 LLY Lilly's Retevmo gains approval for children as young as two with thyroid cancer
May 29 LLY Ro provides supply tracking feature for Lilly, Novo Nordisk weight loss drugs
Hyperactivity Disorder

Attention deficit hyperactivity disorder (ADHD) is a mental disorder of the neurodevelopmental type. It is characterized by difficulty paying attention, excessive activity, or difficulty controlling behavior which is not appropriate for a person's age. The symptoms appear before a person is twelve years old, are present for more than six months, and may cause problems in at least two settings (such as school, home, or recreational activities). In children, problems paying attention may result in poor school performance. Additionally there is an association with other mental disorders and substance misuse. Although it causes impairment, particularly in modern society, many people with ADHD can have sustained attention span for tasks they find interesting or rewarding (known as hyperfocus).Despite being the most commonly studied and diagnosed mental disorder in children and adolescents, the exact cause is unknown in the majority of cases. It affects about 5–7% of children when diagnosed via the DSM-IV criteria and 1–2% when diagnosed via the ICD-10 criteria. As of 2015 it is estimated to affect about 51.1 million people globally. Rates are similar between countries and depend mostly on how it is diagnosed. ADHD is diagnosed approximately two times more often in boys than in girls, although the disorder is often overlooked in girls because their symptoms differ from those of boys. About 30–50% of people diagnosed in childhood continue to have symptoms into adulthood and between 2–5% of adults have the condition. In adults inner restlessness rather than hyperactivity may occur. The condition can be difficult to tell apart from other conditions, as well as to distinguish from high levels of activity that are still within the range of normative behaviors.ADHD management recommendations vary by country and usually involve some combination of counseling, lifestyle changes, and medications. The British guideline only recommends medications as a first-line treatment in children who have severe symptoms and for medication to be considered in those with moderate symptoms who either refuse or fail to improve with counseling, though for adults medications are a first-line treatment. Canadian and American guidelines recommend that medications and behavioral therapy be used together as a first-line therapy, except in preschool-aged children. Stimulant medication therapy is not recommended as a first-line therapy in preschool-aged children in either guideline. Treatment with stimulants is effective for at least 14 months; however, their long term effectiveness is unclear. Adults often develop coping skills which make up for some or all of their impairments.The medical literature has described symptoms similar to those of ADHD since the 18th century. ADHD, its diagnosis, and its treatment have been considered controversial since the 1970s. The controversies have involved clinicians, teachers, policymakers, parents, and the media. Topics include ADHD's causes and the use of stimulant medications in its treatment. Most healthcare providers accept ADHD as a genuine disorder in children and adults, and the debate in the scientific community mainly centers on how it is diagnosed and treated. The condition was officially known as attention-deficit disorder (ADD) from 1980 to 1987, while before this it was known as hyperkinetic reaction of childhood.

Browse All Tags